Qualigen therapeutics posts q1 loss per share of $2.12

Qualigen therapeutics announces business highlights and first quarter fiscal year 2021 financial results; has $16 million in cash on hand as of today.q1 loss per share $2.12.q1 revenue $900,000 versus $1.5 million.

QLGN Ratings Summary

QLGN Quant Ranking